Clasp Therapeutics

Rockville, MD · Founded 2020 · Privately Held (backing)

Developer of a precision oncology platform designed to support the development of targeted therapies for hard-to-treat cancers. Clasp Therapeutics is based in Rockville, MD and was founded in 2020. Its last reported valuation was $192 million in Dec 2023. It has raised $150 million.

Last reported valuation
$191.5M
Oct 2026
Priced at
—
Total raised
$150.0M
Last round
—

Who backs Clasp Therapeutics?

16 investors
InvestorType
Alexandria Venture InvestmentsOther
Novo HoldingsOther
Catalio Capital ManagementVenture capital
Spur Capital PartnersFund of funds
Vivo CapitalVenture capital
BrightEdgeVenture capital
DEGPE / buyout
PictetOther
Third Rock VenturesVenture capital
ACS BrightEdge—
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Clasp Therapeutics investors

16 investors are on record for Clasp Therapeutics, including Alexandria Venture Investments, Novo Holdings, Catalio Capital Management and Spur Capital Partners. By type, the record holds 4 venture capital firms and 1 private equity firm.

Free account
More of Clasp Therapeutics with a free account
  • ·The complete investor list: 16 names
  • ·Watch Clasp Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Clasp Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View